Maurizio Bonati is professor of public health at the Istituto di Ricerche Farmacologiche Mario Negri IRCSS in Milan, Italy.
Maurizio Bonati
Professor
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
From this contributor
Clinicians should consider off-label treatments for autism
Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.
Clinicians should consider off-label treatments for autism
Explore more from The Transmitter
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
BRAIN Initiative researchers ‘dream big’ amid shifts in leadership, funding
But whether the initiative’s road map for the next decade is feasible remains an open question.
Neuroscience, BRAIN Initiative gain budget in ‘bad’ NIH funding bill
The bill goes before the House of Representatives today and outlines increases for neuroscience-related research—including a 33 percent increase to the BRAIN Initiative—but maintains a multiyear spending approach that could limit the number of grants awarded overall.
Neuroscience, BRAIN Initiative gain budget in ‘bad’ NIH funding bill
The bill goes before the House of Representatives today and outlines increases for neuroscience-related research—including a 33 percent increase to the BRAIN Initiative—but maintains a multiyear spending approach that could limit the number of grants awarded overall.
Prenatal viral injections prime primate brain for study
The approach makes it possible to deploy tools such as CRISPR and optogenetics across the monkey brain before birth.
Prenatal viral injections prime primate brain for study
The approach makes it possible to deploy tools such as CRISPR and optogenetics across the monkey brain before birth.